CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease ; volume:8 ; number:1 ; day:25 ; month:1 ; year:2011 ; pages:1-7 ; date:12.2011
Journal of neuroinflammation ; 8, Heft 1 (25.1.2011), 1-7, 12.2011
- Creator
-
Pabon, Mibel M.
- Contributor
-
Bachstetter, Adam D.
Hudson, Charles E.
Gemma, Carmelina
Bickford, Paula C.
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-8-9
- URN
-
urn:nbn:de:1111-2016032329899
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pabon, Mibel M.
- Bachstetter, Adam D.
- Hudson, Charles E.
- Gemma, Carmelina
- Bickford, Paula C.
- SpringerLink (Online service)
Other Objects (12)
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
Radix Scrophulariae extracts (harpagoside) suppresses hypoxia-induced microglial activation and neurotoxicity
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity
The brain's best friend: microglial neurotoxicity revisited
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
Apomorphine Reduces A53T α-Synuclein-Induced Microglial Reactivity Through Activation of NRF2 Signalling Pathway
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
Radix Scrophulariae extracts (harpagoside) suppresses hypoxia-induced microglial activation and neurotoxicity
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity
The brain's best friend: microglial neurotoxicity revisited
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
Apomorphine Reduces A53T α-Synuclein-Induced Microglial Reactivity Through Activation of NRF2 Signalling Pathway
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
Radix Scrophulariae extracts (harpagoside) suppresses hypoxia-induced microglial activation and neurotoxicity
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity
The brain's best friend: microglial neurotoxicity revisited
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein